Table 2.
The associations of individual LTL-associated SNPs with the risks of recurrence and death
| SNP ID | Chr. | Position | Gene | Allele* | SNP-LTL | SNP-Recurrence | SNP-Death | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||||||
| EAF* | β* | β** | HR** (95% CI) | P value | β** | HR** (95% CI) | P value | |||||
| rs11125529 | 2 | 54475866 | ACYP2 | A/C | 0.14 | 0.07 | -0.15 | 0.86 (0.69-1.08) | 0.206 | -0.14 | 0.87 (0.70-1.09) | 0.222 |
| rs6772228 | 3 | 58376019 | PXK | T/A | 0.94 | 0.04 | -0.32 | 0.72 (0.52-1.02) | 0.062 | -0.02 | 0.98 (0.67-1.42) | 0.901 |
| rs10936599 | 3 | 169492101 | TERC | C/T | 0.75 | 0.10 | -0.05 | 0.95 (0.81-1.12) | 0.542 | -0.16 | 0.85 (0.73-1.00) | 0.047 |
| rs7675998 | 4 | 164007820 | NAF1 | G/A | 0.77 | 0.05 | -0.16 | 0.85 (0.73-0.99) | 0.043 | -0.05 | 0.95 (0.81-1.12) | 0.567 |
| rs2736100 | 5 | 1286516 | TERT | C/A | 0.51 | 0.09 | 0.02 | 1.02 (0.89-1.17) | 0.781 | -0.02 | 0.98 (0.86-1.11) | 0.724 |
| rs9420907 | 10 | 105676465 | OBFC1 | C/A | 0.13 | 0.14 | -0.05 | 0.95 (0.78-1.15) | 0.592 | -0.16 | 0.85 (0.70-1.03) | 0.101 |
| rs3027234 | 17 | 8136092 | CTC1 | C/T | 0.78 | 0.10 | -0.09 | 0.91 (0.76-1.09) | 0.316 | -0.01 | 0.99 (0.84-1.18) | 0.937 |
| rs8105767 | 19 | 22215441 | ZNF208 | G/A | 0.29 | 0.06 | 0.01 | 1.01 (0.88-1.17) | 0.873 | 0.00 | 1.00 (0.87-1.15) | 0.983 |
| rs6028466 | 20 | 38129002 | DHX35 | A/G | 0.06 | 0.06 | -0.03 | 0.97 (0.73-1.29) | 0.834 | -0.02 | 0.98 (.075-1.29) | 0.898 |
| rs755017 | 20 | 62421622 | ZBTB46 | G/A | 0.12 | 0.02 | 0.08 | 1.08 (0.89-1.31) | 0.436 | -0.10 | 0.91 (0.74-1.10) | 0.321 |
Alleles are short allele/long allele. Short alleles are used as the reference allele and long allele as effect allele. EAF: effect allele frequency;
β estimates of SNP-LTL association were from published GWAS;
β estimates for SNP-recurrence and SNP-Survival were from this study.
Adjusted by age, smoking status, BMI, histology, stage, grade, and treatment.